DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

Mizuho Reiterates Buy on Akebia Therapeutics, Lowers Price Target to $15

Mizuho reiterates Akebia Therapeutics (NASDAQ:AKBA) with a Buy and lowers the price target from $16 to $15.

Benzinga · 03/11/2020 11:39

Mizuho reiterates Akebia Therapeutics (NASDAQ:AKBA) with a Buy and lowers the price target from $16 to $15.